NAME |
VA-TETANUS/DIPHTHERIA/PERTUSSIS (TDAP) IMMUNIZATION |
PRINT NAME |
Tdap Immunization |
DO IN ADVANCE TIME FRAME |
6M |
CLASS |
NATIONAL |
SPONSOR |
NATIONAL CENTER FOR HEALTH PROMOTION AND DISEASE PREVENTION (NCP) |
USAGE |
CR |
EDIT HISTORY |
-
- EDIT DATE: 2016-05-23 13:06:01
- EDIT BY: USER,FIFTYFOUR
- EDIT COMMENTS:
Exchange Install
|
DESCRIPTION |
A single dose of Tdap (Tetanus Toxoid, Reduced Diphtheria Toxoid and
A history of encephalopathy (e.g., coma or prolonged seizures)
not attributable to an identifiable cause within 7 days of
administration of a vaccine with pertussis components. This
contraindication is for the pertussis components, and these persons
should receive Td instead of Tdap.
PREGNANT/BREASTFEEDING WOMEN:
Women's health care providers should implement a Tdap
vaccination program for pregnant women. Health care providers should
administer Tdap during each pregnancy, preferably during the third
Acellular Pertussis vaccine) should be given regardless of when the last
trimester (between 27-36 weeks gestation), although Tdap may be given at
any time during pregnancy. If Tdap is not administered during pregnancy,
Tdap should be administered immediately postpartum.
The rationale for repeat vaccination during each pregnancy is
that reported cases of pertussis continue to increase, uptake of Tdap
vaccine among pregnant women remains low and new data indicate that
maternal anti-pertussis antibodies are short-lived, thus Tdap
vaccination in one pregnancy will not provide high levels of antibodies
to protect newborns during subsequent pregnancies. The rationale for
administration during the third trimester (between 27-36 weeks
Tetanus containing product was received in adults who have not previously
gestation) is that this would provide the highest concentration of
maternal antibodies to be transferred closer to birth, but also allow
for the 2 weeks (before birth) required to mount a maximal immune
response to the vaccine antigens.
received Tdap. In addition, pregnant women should receive an additional
dose during each pregnancy.
TdaP Contraindications:
A history of serious allergic reaction (i.e., anaphylaxis) to any
component of the vaccine.
|
FINDINGS |
-
- FINDING ITEM: VA-TDAP IMMUNIZATION
- NO. OF FOUND TEXT LINES: 0
- NO. NOT FOUND TEXT LINES: 0
- USE IN RESOLUTION LOGIC: OR
- BEGINNING DATE/TIME: 06/01/2006
-
- FINDING ITEM: VA-TDAP CONTRAINDICATION
- WITHIN CATEGORY RANK: 0
- NO. OF FOUND TEXT LINES: 0
- NO. NOT FOUND TEXT LINES: 0
-
- FINDING ITEM: VA-TDAP DEFERRALS
- WITHIN CATEGORY RANK: 0
- NO. OF FOUND TEXT LINES: 0
- NO. NOT FOUND TEXT LINES: 0
-
- FINDING ITEM: VA-TDAP ORDERS
- ENDING DATE/TIME: T+14D
- NO. OF FOUND TEXT LINES: 0
- NO. NOT FOUND TEXT LINES: 0
- BEGINNING DATE/TIME: T-14D
|
TECHNICAL DESCRIPTION |
**Since Tdap was NOT available before 2005 and was NOT given at this
have been in use at a VAMC to indicate the following items:
Tdap Immunization Refusal
Acute Febrile Illness
Any finding in this Reminder Term will resolve the reminder for
predetermined amount of time.
The Reminder Term, "VA-TDAP CONTRAINDICATION", contains
Computed Findings looking for allergies to TETANUS, DIPHTHERIA or
PERTUSSIS that have been documented in the Allergy/Adverse Drug Reaction
package. If found, the reminder will not apply - AND NOT Cohort Logic.
facility prior to 2006, any record of Tdap prior to these dates will be
Health Factors in use locally to document allergy to Td should also be
included in this Reminder Term.
Reminder Term, "VA-TDAP ORDER" should contain any orders for the Tdap
vaccine. Sites should map any orders that are used for the Tdap
vaccine. The reminder will be resolved for 28 days by the order for TdaP
vaccine.
COHORT:
-Not applicable for patients with a Tdap Contraindication
ignored and assumed to be an incorrect entry.
RESOLUTION:
-Tdap Immunization
-Tdap Deferrals
-Tdap Orders
Reminder Term, "VA-TDAP IMMUNIZATION" includes the standardized
immunization for Tdap. Sites should also include any locally
created immunizations that were used for Tdap vaccines.
Reminder Term "VA-TDAP DEFERRALS" should include any Health Factors that
|
CUSTOMIZED COHORT LOGIC |
(SEX)&(AGE)&'FI(2) |
INTERNAL PATIENT COHORT LOGIC |
(SEX)&(AGE)&'FI(2) |
PATIENT COHORT FINDINGS COUNT |
3 |
PATIENT COHORT FINDINGS LIST |
SEX;AGE;2 |
CUSTOMIZED RESOLUTION LOGIC |
FI(1)!FI(3)!FI(4) |
INTERNAL RESOLUTION LOGIC |
FI(1)!FI(3)!FI(4) |
RESOLUTION FINDINGS COUNT |
3 |
RESOLUTION FINDINGS LIST |
1;3;4 |
WEB SITES |
-
- URL: http://vaww.prevention.domain.ext/Tetanus_Diphtheria_Td_and_Tetanus_Diphtheria_Pertussis_Tdap_Immunizations.asp
-
- URL: http://www.cdc.gov/vaccines/hcp/vis/vis-statements/tdap.html
-
- URL: http://www.cdc.gov/mmwr/preview/mmwrhtml/00041645.htm
-
- URL: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6001a4.htm?s_cid=mm6001a4_w
|
# OF GEN. COHORT FOUND LINES |
0 |
# GEN. COHORT NOT FOUND LINES |
0 |
# GEN. RES. FOUND LINES |
0 |
# GEN. RES. NOT FOUND LINES |
0 |
BASELINE AGE FINDINGS |
-
- REMINDER FREQUENCY: 99Y
- MINIMUM AGE: 19
- AGE MATCH TEXT:
Tdap due once for patients 19 and over.
- NO. OF AGE MATCH LINES: 1
- NO. OF AGE NO MATCH LINES: 0
|
# SUM. COHORT FOUND LINES |
0 |
# SUM. COHORT NOT FOUND LINES |
0 |
# SUM. RES. FOUND LINES |
0 |
# SUM. RES. NOT FOUND LINES |
0 |